Insider Holders & Insider Ownership - REGENERON PHARMACEUTICALS INC. (REGN)

List of insiders holdings for REGENERON PHARMACEUTICALS INC.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time		Shares Owned
Directly
Indirectly		Total
Shares Owned		Filing
SCHLEIFER LEONARD S
Bd. Co-Chair, President & CEO		2024-06-13 16:01:192,177,667
178,259		2,355,926Form 4
YANCOPOULOS GEORGE
Bd. Co-Chair, President & CSO		2024-06-12 16:10:49868,994
241,951		1,110,945Form 4
VAGELOS P ROY
Director		2023-04-05 16:02:23312,578
154,526		467,104Form 4
SANOFI-AVENTIS
Sanofi-Aventis Amerique du Nord S.N.C.
10% Owner		2020-06-17 17:10:15279,766
0		279,766Form 13D
Sanofi
10% Owner		2020-06-17 17:10:15279,766
0		279,766Form 13D
GOLDBERG MURRAY A
SVP Administration & Asst Secr		2014-12-18 16:25:06142,515
6,400		148,915Form 4
RUPP RANDALL
SVP, Manufuring Operations		2007-04-17 14:25:18142,137
0		142,137Form 4
ROBERTS WILLIAM
VP Reg Dev & Med Safety		2014-02-06 16:41:1816,644
55,634		72,278Form 5
GULER HANS PETER
VP Clinical Programs		2004-10-12 12:02:0867,152
0		67,152Form 4
STAHL NEIL
EVP Research and Development		2024-08-14 16:01:1949,599
10,454		60,053Form 4
MURPHY ANDREW J
EVP Research		2024-11-12 16:03:1147,121
4,326		51,447Form 4
LAROSA JOSEPH J
EVP General Counsel and Secret		2024-07-12 16:00:1737,937
371		38,308Form 4
Landry Robert E
EVP Finance CFO		2024-02-06 16:08:1735,480
270		35,750Form 4
Powchik Peter
SVP Clinical Development & Reg		2016-12-19 16:15:0630,714
4,133		34,847Form 4
Van Plew Daniel P
EVP & General Mgr, Industrial		2024-02-16 16:15:3220,378
13,460		33,838Form 4
Terifay Robert J
EVP Commercial		2017-12-13 16:52:2932,300
0		32,300Form 4
SING GEORGE L
Director		2024-09-05 16:01:5726,272
2,150		28,422Form 4
Dworkin Peter
VP Investor Relations & Commun		2009-12-22 11:21:1323,500
0		23,500Form 4
SHOOTER ERIC M
Director		2014-02-13 19:38:0915,000
5,085		20,085Form 4
KOLINSKI STUART
SVP General Counsel and Secret		2010-06-07 16:14:1016,329
3,710		20,039Form 4
Aberman Michael S
SVP Strategy Investor Relation		2017-06-23 16:10:087,693
12,253		19,946Form 4
McCourt Marion
EVP Commercial		2024-11-05 16:23:0418,931
174		19,105Form 4
Fenimore Christopher R.
SVP Finance & CFO		2024-08-29 16:27:4015,305
3,437		18,742Form 4
RYAN ARTHUR F
Director		2024-10-03 16:02:2117,582
0		17,582Form 4
INGRAM ROBERT ALEXANDER
Director		2015-05-27 16:02:3514,833
0		14,833Form 4
BROWN MICHAEL S
Director		2024-06-17 16:01:481,382
11,162		12,544Form 4
McCorkle Douglas S
VP Controller and Asst Treasur		2015-12-29 19:44:106,866
4,129		10,995Form 4
GILMAN ALFRED G
Director		2015-08-07 18:15:048,912
0		8,912Form 4
BAKER CHARLES A
Director		2018-01-03 16:14:217,439
0		7,439Form 4
GOLDSTEIN JOSEPH L
Director		2024-01-25 16:18:366,382
0		6,382Form 4
Tessier-Lavigne Marc
Director		2023-01-05 16:16:354,363
0		4,363Form 4
Pitofsky Jason
VP Controller		2024-08-07 16:40:114,204
10		4,214Form 4
COLES N ANTHONY
Director		2024-01-04 16:11:273,000
0		3,000Form 4
Zoghbi Huda Y
Director		2024-01-04 16:11:182,989
0		2,989Form 4
Bassler Bonnie L
Director		2024-08-19 16:02:052,898
0		2,898Form 4
POON CHRISTINE A
Director		2024-08-19 16:01:372,172
0		2,172Form 4
Thompson Craig B.
Director		2024-01-04 16:15:452,061
0		2,061Form 4
Schenkein David P
Director		2024-01-04 16:17:15790
0		790Form 4
Guarini Kathryn
Director		2024-01-04 16:16:40790
0		790Form 4
NOVARTIS PHARMA AG
10% Owner		2005-11-10 14:56:080
0		0Form 13G